Future prospective multicenter cohorts should enroll diverse COPD patients with acute lower respiratory infections across severity strata, employing standardized CRP assays alongside inflammatory mediators (IL-6, TNF-α). Here, TNF is linked to chronic obstructive pulmonary disease.